TOXOPLASMOSIS TREATMENT DRUGS MARKET ANALYSIS

Toxoplasmosis Treatment Drugs Market by Drug Class (Pyrimethamine, Spiramycin, Leucovorin, Sulfadiazine, Folic Acid, and Others), by Indication (Chronic Toxoplasmosis Infection and Acute Toxoplasmosis Infection), by Route of Administration (Parenteral and Oral), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jul 2023
Code : CMI4166
Pages :250
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

The major players operating in the global toxoplasmosis treatment drugs market include Vyera Pharmaceuticals LLC, Taj Accura Pharmaceuticals Ltd, Mangalam Drugs and Organics Ltd, Cerovene Healthcare PVT LTD, Greenstone LLC, Amneal Pharmaceuticals, Inc., Turing Pharmaceuticals, Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd, and Baxter International Inc.